Alprostadil topical - VIVUS

Drug Profile

Alprostadil topical - VIVUS

Alternative Names: ALISTA; Prostaglandin E1 topical - VIVUS

Latest Information Update: 10 Jun 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator VIVUS
  • Developer AndroSolutions; Asivi; VIVUS
  • Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Female sexual dysfunction

Most Recent Events

  • 10 Jun 2009 Discontinued - Phase-II for Female sexual dysfunction in USA (Topical)
  • 03 Oct 2006 Final results from a phase IIb clinical trial in patients with Female sexual arousal disorder have been added to the Women's Health therapeutic trials section
  • 07 Dec 2005 VIVUS has completed enrolment in the phase IIb trial for Female sexual dysfunction in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top